ATA 2026 | Exchange Frontiers, Explore New Directions in Thyroid Minimally Invasive Ablation


Release time:

2026-11-17

DEVIN MEDICAL at ATA 2026: Advancing Thyroid Minimally Invasive Ablation

The 2026 Annual Meeting of the American Thyroid Association (ATA) was held in Philadelphia, USA, from November 4 to 7. Devin Medical attended the conference with its self-developed microwave ablation system. The team engaged in discussions with international clinicians and partners on clinical demands, technical applications and future directions of minimally invasive interventional therapy for thyroid conditions.

Focusing on cutting-edge disciplines and advances in minimally invasive therapy

The ATA Annual Meeting gathers clinicians and researchers in thyroidology, serving as a key platform to share updates on diagnosis, treatment and real-world clinical experience. This year’s programme featured sessions on interventional endocrinology, covering ablation therapy for thyroid diseases and nodules, including indications, procedural techniques and complication management.

As thyroid care evolves toward precision, minimal invasiveness and individualisation, image-guided thermal ablation has attracted growing clinical interest. At the conference, the Devin Medical team kept abreast of the latest advances and exchanged insights with global peers on the clinical adoption of thyroid microwave ablation.

Showcasing a precision ablation portfolio tailored for thyroid procedures

Devin Medical commits to independent R&D of microwave ablation generators, ablation needles and supporting technologies for thyroid interventions. The displayed microwave ablation system is optimised for thyroid use, with coordinated hardware and consumables, alongside built-in procedural monitoring to underpin safe minimally invasive treatment.

Moving from standalone devices to integrated solution suites, Devin Medical aligns technical innovation with clinical needs. Its presence at ATA 2026 demonstrated the company’s R&D strengths in precision ablation, while opening doors to learn from international clinical practices.

Deepening expert dialogue and gathering on-site feedback

Face-to-face discussions were held with clinical specialists and partners regarding the clinical use, product adaptation and technical roadmap of thyroid microwave ablation. The dedicated thyroid-focused microwave ablation platform and complete supporting portfolio drew positive attention. Valuable on-site input will guide future product refinement.

Feedback from diverse clinical and collaborative stakeholders helps the team address priorities for standardised deployment of ablation technologies. Devin Medical will incorporate these insights to tightly link R&D with clinical realities.

Sustained R&D and global academic collaboration

Participation in ATA 2026 marks another milestone for Devin Medical in international academic exchange and global showcasing of homegrown innovations. Going forward, the company will continue to prioritise precision ablation, refine its microwave ablation systems and accessories, and strengthen collaboration with clinicians and partners worldwide. Together, we aim to advance standardised practice and development of thyroid minimally invasive ablation.

DEVIN MEDICAL Precision Ablation, Connecting the World